Evidence map›Paper›PMID 42746264›Full record

ArticleCell biomaterials2026

Digital Light Processing 3D Printing Enables Versatile Fabrication of Human Engineered Heart Tissues.

Abhishek P Dhand, Miranda A Juarros, Thomas G Martin, Manuela Garay-Sarmiento, Christina Alamana, Dakota R Hunt, Gabriel J Rodriguez-Rivera, Mackenzie C Obenreder, Cody O Crosby, Bianca Meurer-Zeman and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Abhishek P DhandDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Miranda A JuarrosBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Thomas G MartinBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Manuela Garay-SarmientoBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Christina AlamanaBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Dakota R HuntBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Gabriel J Rodriguez-RiveraBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Mackenzie C ObenrederBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Cody O CrosbyDepartment of Physics, Southwestern University, Georgetown, TX, 78626.
Bianca Meurer-ZemanBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Quentin McAfeeBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Henry Valle-AyalaBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Hannah M ZlotnickBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Declan N GoddardBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
Christopher C EbmeierDepartment of Biochemistry, University of Colorado, Boulder, CO 80303, USA.
Jason A BurdickDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Leslie A LeinwandBioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.

Funding

MYOSIN GENE DIVERSITY AND FUNCTIONR01GM029090 · NIGMS · YESHIVA UNIVERSITY · PI Leslie Anne Leinwand · 1985 to 2026
$12.3M
Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
Engineered Granular Hydrogels for Endogenous Tissue RepairR01HL160616 · NHLBI · UNIVERSITY OF COLORADO · PI BURDICK, JASON A · 2022 to 2025
$2.5M
Interdisciplinary Training in Musculoskeletal ResearchT32AR080630 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Karin A Payne, MICHAEL J ZUSCIK · 2022 to 2026
$1.7M
The role of FOXO1 in the development and regression of cardiac hypertrophyF32HL170637 · NHLBI · UNIVERSITY OF COLORADO · PI MARTIN, THOMAS GWYNN · 2023 to 2024
$96k
NHLBI NIH HHS F32 HL170637NHLBI NIH HHS R01 HL160616NIAMS NIH HHS T32 AR080630NIGMS NIH HHS R01 GM029090NIGMS NIH HHS T32 GM142607
6 · The paper itself

Abstract

Investigations into cardiac biology and drug discovery benefit from

Identifiers

PMID42746264
PMCPMC13576525

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.